Hope for Depression and Other Diagnoses with Psychedelics
Psychedelic clinical trials for major depression, anxiety, PTSD, and other disorders are ongoing, with a recent positive Phase 3 trial for psilocybin in treatment-resistant depression.
Integrated Care for Depression Yields Extended Benefits, Malawi Study Shows
Integrating depression treatment with chronic health care enhances patient and family well-being, addressing significant gaps in mental health services.
Integrated Care for Depression Yields Extended Benefits, Malawi Study Shows
Integrating depression treatment with chronic health care enhances patient and family well-being, addressing significant gaps in mental health services.